✦ LIBER ✦

Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer

✍ Scribed by Rupert Bartsch; Catharina De Vries; Ursula Pluschnig; Peter Dubsky; Zsuzsanna Bago-Horvath; Simon P Gampenrieder; Margaretha Rudas; Robert M Mader; Andrea Rottenfusser; Christoph Wiltschke; Michael Gnant; Christoph C Zielinski; Guenther G Steger

Book ID: 115011725
Publisher: BioMed Central
Year: 2009
Tongue: English
Weight: 644 KB
Volume: 9
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-9-367

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5088 Analysis of factors predicting resp

5088 Analysis of factors predicting response to second-line trastuzumab- based therapy in patients (pts) with Her2-positive advanced breast cancer (ABC)

✍ R. Bartsch; C. DeVries; U. Pluschnig; P. Dubsky; S. Horvath; M. Rudas; R.M. Made 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Trastuzumab-based neoadjuvant therapy in

Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer

✍ Helena R. Chang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB 👁 2 views

Trastuzumab Emtansine: A Review of Its U

Trastuzumab Emtansine: A Review of Its Use in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab-Based Therapy

✍ Dhillon, Sohita 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 402 KB

5075 Sunitinib plus docetaxel and trastu

5075 Sunitinib plus docetaxel and trastuzumab as first-line therapy for HER2+ advanced breast cancer

✍ F. Cardoso; J.L. Canon; D. Amadori; L. Dirix; E. Villa; D. Aldrighetti; J.P. Mac 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Hormone-receptor expression and activity

Hormone-receptor expression and activity of trastuzumab with chemotherapy in HER2-positive advanced breast cancer patients

✍ Filippo Montemurro; Valentina Rossi; Maria Cossu Rocca; Rossella Martinello; Ele 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB 👁 2 views

Phase Ib Study of Buparlisib plus Trastu

Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy

✍ Saura, C.; Bendell, J.; Jerusalem, G.; Su, S.; Ru, Q.; De Buck, S.; Mills, D.; R 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 898 KB